NIKA · Nika Pharmaceuticals, Inc
$0.41
At close · Aug 26
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 10, 2026
Market Cap
$431.19M
Shares
1.05B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 10-K | 2026-03-25 | 2025-12-31 | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q/A | 2024-11-01 | 2024-06-30 | |
| 8-K | 2024-10-16 | 2024-10-02 | |
| 8-K | 2024-10-01 | 2024-09-23 | |
| 10-Q | 2024-09-18 | 2024-06-30 | |
| 8-K | 2024-08-27 | 2024-08-18 | |
| 10-Q | 2024-05-28 | 2024-03-31 | |
| 8-K | 2024-05-10 | 2024-04-23 | |
| 8-K | 2024-04-15 | 2024-04-10 | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-03-05 | 2024-03-01 | |
| 8-K | 2024-02-16 | 2024-02-14 | |
| 10-Q | 2023-10-31 | 2023-09-30 | |
| 8-K | 2023-09-18 | — | |
| 10-Q | 2023-08-21 | 2023-06-30 | |
| 10-Q | 2023-05-15 | 2023-03-31 | |
| 10-K | 2023-04-10 | 2022-12-31 | |
| 8-K | 2022-11-15 | 2022-11-12 | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| 10-Q/A | 2022-11-07 | 2022-06-30 | |
| 8-K | 2022-11-01 | 2022-10-31 | |
| 10-Q | 2022-08-22 | 2022-06-30 | |
| 8-K | 2022-08-22 | — | |
| 10-Q | 2022-05-12 | 2022-03-31 | |
| 8-K | 2022-04-12 | — | |
| 8-K | 2022-04-05 | — | |
| 10-K | 2022-03-03 | 2021-12-31 | |
| 10-Q | 2021-11-12 | 2021-09-30 | |
| 10-Q | 2021-08-11 | 2021-06-30 | |
| 10-Q | 2021-05-13 | 2021-03-31 | |
| 10-K/A | 2021-03-25 | 2020-12-31 | |
| 10-K | 2021-03-24 | 2020-12-31 |
Showing 1–39 of 39 filings